Cancer Genomics Consortium (CGC) Annual Meeting 2022

The genetic underpinnings of cancer are diverse and many types of genomic aberration — from SNVs to SVs, fusion transcripts, and epigenetic modifications (e.g. DNA/RNA methylation) — can cause, contribute to, or indicate disease. As a result, researchers traditionally relied on multiple techniques to identify and analyse different forms of cancer. Now, through the facility to generate sequencing reads of any length, including ultra-long reads in excess of 4 Mb that can span complex genomic regions, combined with integrated base modification detection and real-time results, nanopore sequencing delivers a streamlined and rapid solution for complete characterisation of cancer samples.

We're looking forward to CGC 2022. Visit the Oxford Nanopore booth to speak to our experts about your application or set up a meeting time by logging your interest here: https://nanoporetech.com/contact